Venetoclax-based therapies in pediatric advanced MDS and relapsed/refractory AML: a multicenter retrospective analysis.
Masetti R, Baccelli F, Leardini D, Gottardi F, Vendemini F, Di Gangi A, Becilli M, Lodi M, Tumino M, Vinci L, Erlacher M, Strahm B, Niemeyer CM, Locatelli F.
Masetti R, et al. Among authors: vendemini f.
Blood Adv. 2023 Aug 22;7(16):4366-4370. doi: 10.1182/bloodadvances.2023010113.
Blood Adv. 2023.
PMID: 37216275
Free PMC article.
No abstract available.